软骨
骨关节炎
分解代谢
软骨细胞
促炎细胞因子
细胞生物学
信号转导
医学
MAPK/ERK通路
滑膜关节
内科学
生物
炎症
解剖
病理
新陈代谢
关节软骨
替代医学
作者
Yihan Liao,Yinshi Ren,Xin Luo,Anthony J. Mirando,Jason S. Long,Abigail Leinroth,Ru-Rong Ji,Matthew J. Hilton
出处
期刊:Science Signaling
[American Association for the Advancement of Science (AAAS)]
日期:2022-07-26
卷期号:15 (744)
被引量:10
标识
DOI:10.1126/scisignal.abn7082
摘要
Osteoarthritis (OA) and posttraumatic OA (PTOA) are caused by an imbalance in catabolic and anabolic processes in articular cartilage and proinflammatory changes throughout the joint, leading to joint degeneration and pain. We examined whether interleukin-6 (IL-6) signaling contributed to cartilage degradation and pain in PTOA. Genetic ablation of Il6 in male mice decreased PTOA-associated cartilage catabolism, innervation of the knee joint, and nociceptive signaling without improving PTOA-associated subchondral bone sclerosis or chondrocyte apoptosis. These effects were not observed in female Il6-/- mice. Compared with wild-type mice, the activation of the IL-6 downstream mediators STAT3 and ERK was reduced in the knees and dorsal root ganglia (DRG) of male Il6-/- mice after knee injury. Janus kinases (JAKs) were critical for STAT and ERK signaling in cartilage catabolism and DRG pain signaling in tissue explants. Whereas STAT3 signaling was important for cartilage catabolism, ERK signaling mediated neurite outgrowth and the activation of nociceptive neurons. These data demonstrate that IL-6 mediates both cartilage degradation and pain associated with PTOA in a sex-specific manner and identify tissue-specific contributions of downstream effectors of IL-6 signaling, which are potential therapeutic targets for disease-modifying OA drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI